The DOI matches its Crossref record; 456 of the 456 references it cites were found in a registry or an index.
Neurobiological Similarities in Depression and Drug Dependence: A Self-Medication Hypothesis
Abstract
Epidemiological and clinical data indicate high comorbidity between depression and drug dependence that may reflect an attempt to self-medicate with drugs of abuse. The present review examines whether these two psychiatric disorders are related by attempting to identify similarities in the neurobiology of depression and drug dependence. Emphasis is put on the neuromechanisms that may mediate specific core symptoms of both disorders that reflect alterations in reward and motivational processes. First, the epidemiological and clinical data on the comorbidity of the two disorders are reviewed briefly. Then, the neuroadaptations associated with psychomotor stimulant, opiate, ethanol, nicotine, and benzodiazepine dependence in animals are reviewed. Finally, the neurotransmitter systems whose function appears to be altered in depression (i.e., serotonin, norepinephrine, acetylcholine, dopamine, gamma-aminobutyric acid, corticotropin releasing factor, neuropeptide Y, and somatostatin), as revealed primarily by animal studies, are discussed. It is concluded that drug dependence and depression may be associated with alterations in some of the same neurotransmitter systems and, in particular, with alterations of neurotransmitter function in limbic-related brain structures. Thus, these two psychiatric disorders may be linked by some shared neurobiology. Nevertheless, it remains unclear whether drug abuse and depression are different symptomatic expressions of the same preexisting neurobiological abnormalities, or whether repeated drug abuse leads to the abnormalities mediating depression (i.e., drug-induced depressions). The hypothesis of self-medication of non-drug- and drug-induced depressions with drugs of abuse is also discussed as a potentially important explanatory concept in understanding the observed clinical comorbidity of these two psychiatric disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“it is believed that some depressed patients initiate smoking as an attempt to self medicate depressive symptoms with nicotine (Markou et al., 1998; Patton et al., 1998).”
From It is not “either/or”: Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood (2008) · cites this paper as Markou et al., 1998
In the citing paper
“Depression and anxiety are both highly comorbid with nicotine dependence (Paperwalla et al., 2004), and nicotine use may be an attempt at self-medication in these conditions (Markou et al., 1998).”
From Nicotinic Partial Agonists Varenicline and Sazetidine-A Have Differential Effects on Affective Behavior (2010) · cites this paper as Markou et al., 1998
In the citing paper
“These findings suggest that chronic drug taking leading to hypo-activity of the meso-ventromedial striatal dopamine system may result in a negative mood state which in turn accelerates drug-taking (“self-medication”) in an attempt to improve the mood state (Markou et al., 1998).”
From Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complex (2007) · cites this paper as Markou et al., 1998
In the citing paper
“According to the self-medication hypothesis of nicotine dependence (Carmody, 1992; Markou, Kosten, & Koob, 1998; Pomerleau & Pomerleau, 1985), this might be because nicotine reduces negative affect and works as an antidepressant.”
From Nicotine addiction and psychiatric disorders (2015) · cites this paper as Markou et al., 1998
Citations
Cites
Items 201–400 of 456
Banki, C. M., Karmacsi, L., Bissette, G., & Nemeroff, C. B. (1992) · European Neuropsychopharmacology · doi:10.1016/0924-977x(92)90019-5 · Cited by 149
Cohen, R. M. (1982) · Neuropharmacology · doi:10.1016/0028-3908(82)90091-0 · Cited by 149
Cognitive correlates of life stress and depression in college students.
Hammen, C. L., & Cochran, S. D. (1981) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.90.1.23 · Cited by 149
Plasma GABA in affective illness
Petty, F., & Schlesser, M. A. (1981) · Journal of Affective Disorders · doi:10.1016/0165-0327(81)90003-3 · Cited by 148
Naloxone precipitates nicotine abstinence syndrome in the rat
Malin, D. H., Lake, J. R., Carter, V. A., Cunningham, J. S., & Wilson, O. B. (1993) · Psychopharmacology · doi:10.1007/bf02244930 · Cited by 147
DEPENDENCE LIABILITY OF SEVERAL SEDATIVE-HYPNOTIC AGENTS EVALUATED IN MONKEYS
Yanagita, T., & Takahashi, S. (1973) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29510-6 · Cited by 145
Hrdina, P. D., & Vu, T. B. (1993) · Synapse · doi:10.1002/syn.890140410 · Cited by 145
Chronic mild stress-induced anhedonia model of depression
Moreau, J. ‐., Scherschlicht, R., Jenck, F., & Martin, J. R. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199511000-00003 · Cited by 144
Chronic antidepressant treatment and central 5-HT synapses
Fuxé, K. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90188-0 · Cited by 143
Nicotine Dependence, Midbrain Dopamine Systems and Psychiatric Disorders
Nisell, M., Nomikos, G. G., & Svensson, T. H. (1995) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1995.tb00123.x · Cited by 143
Benzodiazepines as antidepressants: Does GABA play a role in depression?
Petty, F., Trivedi, M. H., Fulton, M., & Rush, A. J. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00049-7 · Cited by 143
Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal
Koob, G. F., Wall, T. L., & Bloom, F. E. (1989) · Psychopharmacology · doi:10.1007/bf00441954 · Cited by 142
Corticotropin releasing factor, stress and behavior
Koob, G. F., Heinrichs, S. C., Menzaghi, F., Pich, E. M., & Britton, K. T. (1994) · Seminars in Neuroscience · doi:10.1006/smns.1994.1029 · Cited by 141
McBride, W. J. H., Murphy, J. M., Lumeng, L., et al. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90137-2 · Cited by 139
Green, A. R., & Deakin, J. F. W. (1980) · Nature · doi:10.1038/285232a0 · Cited by 138
Role of noradrenergic and dopaminergic processes in amphetamine self-administration
Risner, M. E., & Jones, B. E. (1976) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(76)90113-1 · Cited by 137
Morrow, A. L., Montpied, P., Lingford-Hughes, A. R., & Paul, S. M. (1990) · Alcohol · doi:10.1016/0741-8329(90)90012-2 · Cited by 136
Effect of Nicotine Replacement on the Cigarette Withdrawal Syndrome
West, R., Jarvis, M. J., Russell, M. A., Carruthers, M. E., & Feyerabend, C. (1984) · British Journal of Addiction · doi:10.1111/j.1360-0443.1984.tb00265.x · Cited by 136
Epping-Jordan, M. P., Markou, A., & Koob, G. F. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01190-6 · Cited by 135
Self-citation5-HT receptor binding in post-mortem brain from patients with affective disorder
McKeith, I. G. (1987) · Journal of Affective Disorders · doi:10.1016/0165-0327(87)90075-9 · Cited by 134
Taylor, J. R., Elsworth, J. D., Garcia, E. J., Grant, S. J., Roth, R. H., & Redmond, D. E. (1988) · Psychopharmacology · doi:10.1007/bf02431544 · Cited by 134
Suicidal behavior, impulsiveness and serotonin
Roy, A., & Linnoila, M. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06380.x · Cited by 133
Effects of serotonergic manipulations on cocaine self-administration in rats
Peltier, R., & Schenk, S. (1993) · Psychopharmacology · doi:10.1007/bf02244643 · Cited by 133
Roy, A. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810290040007 · Cited by 133
Haertzen, C. A., & Hooks, N. T. (1969) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196906000-00004 · Cited by 133
Pharmacological treatment of alcohol intoxication, withdrawal and dependence: a critical review.
Liskow, B. I., & Goodwin, D. W. (1987) · Journal of Studies on Alcohol · doi:10.15288/jsa.1987.48.356 · Cited by 131
Guan, X.-M., Peroutka, S. J., & Kobilka, B. K. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09017-0 · Cited by 131
Negus, S. S., Henriksen, S. J., Mattox, A., Pasternak, G. W., Portoghese, P. S., Takemori, A. E., Weinger, M. B., & Koob, G. F. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38246-7 · Cited by 130
Robledo, P., & Koob, G. F. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90112-4 · Cited by 130
Parental concordance for affective disorders: psychopathology in offspring
Merikangas, K. R., Prusoff, B. A., & Weissman, M. M. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90025-0 · Cited by 127
Dopaminergic mechanism of imipramine action in an animal model of depression
Muscat, R., Sampson, D., & Willner, P. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90577-o · Cited by 126
Neuropharmacology of Cocaine and Ethanol Dependence
Koob, G. F., & Weiss, F. (1992) · Recent developments in alcoholism · doi:10.1007/978-1-4899-1648-8_11 · Cited by 124
Florin, S. M., Kuczenski, R. T., & Segal, D. S. (1994) · Brain Research · doi:10.1016/0006-8993(94)91570-9 · Cited by 124
Invernizzi, R. W., Bramante, M., & SAMANIN, R. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90344-1 · Cited by 124
Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories
Caldecott-Hazard, S., Morgan, D., DeLeon-Jones, F. A., Overstreet, D. H., & Janowsky, D. S. (1991) · Synapse · doi:10.1002/syn.890090404 · Cited by 124
Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test
Heilig, M. A., McLeod, S., Koob, G. K., & Britton, K. T. (1992) · Regulatory Peptides · doi:10.1016/0167-0115(92)90514-u · Cited by 123
GABA Antagonist and Benzodiazepine Partial Inverse Agonist Reduce Motivated Responding for Ethanol
Rassnick, S., D'amico, E., Riley, E. P., & Koob, G. F. (1993) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1993.tb00736.x · Cited by 122
Behavioral Pharmacology of Antianxiety Drugs
Sepinwall, J., & Cook, L. (1978) · Springer eBooks · doi:10.1007/978-1-4684-3189-6_6 · Cited by 121
Samson, H. H., Tolliver, G. A., Pfeffer, A. O., Sadeghi, K. G., & Mills, F. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90357-1 · Cited by 121
Porrino, L. J., Ritz, M. C., Goodman, N. L., Sharpe, L. G., Kuhar, M. J., & Goldberg, S. R. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90418-9 · Cited by 121
Affective disorder—VII: Alcoholism and affective disorder
Pitts, F. N., & Winokur, G. (1966) · Journal of Psychiatric Research · doi:10.1016/0022-3956(66)90013-6 · Cited by 121
Antidepressant-like effects of dopamine agonists in an animal model of depression
Muscat, R., Papp, M., & Willner, P. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90119-k · Cited by 120
Klimek, V., & Nielsen, M. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90248-2 · Cited by 118
Chronic antidepressants and GABA “B” receptors: A GABA hypothesis of antidepressant drug action
Pilc, A., & Lloyd, K. G. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90515-0 · Cited by 118
Crews, F. T., Paul, S. M., & Goodwin, F. K. (1981) · Nature · doi:10.1038/290787a0 · Cited by 118
Effects of desipramine and yohimbine on α2- and β-adrenoreceptor sensitivity
Johnson, R. W., Reisine, T., Spotnitz, S. G., et al. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90019-9 · Cited by 117
Drug preference in humans: double-blind choice comparison of pentobarbital, diazepam and placebo.
Griffiths, R. R., Bigelow, G. E., Liebson, I. A., & Kaliszak, J. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32353-0 · Cited by 116
Palmer, G. C., Sulser, F., & Robison, G. A. (1973) · Neuropharmacology · doi:10.1016/0028-3908(73)90092-0 · Cited by 115
Hjorth, S., & Auerbach, S. B. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90346-8 · Cited by 115
Rapid down regulation of β-adrenoceptors by co-administration of desipramine and fluoxetine
Baron, B. M., Ogden, A.-M., Siegel, B. W., et al. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90089-1 · Cited by 114
BRYANT, K. J., Rounsaville, B. J., Spitzer, R. L., & Williams, J. B. W. (1992) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199204000-00007 · Cited by 112
Current concepts on the mechanisms of action of antidepressant drugs
Sugrue, M. F. (1981) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(81)90001-2 · Cited by 109
Repeated electroconvulsive shock attenuates clonidine-induced hypoactivity in rodents
Heal, D. J., Akagi, H., Bowdler, J. M., et al. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90549-5 · Cited by 109
Self-injection of barbiturates and benzodiazepines in baboons
Griffiths, R. R., Lukas, S. E., Bradford, L. D., Brady, J. V., & Snell, J. D. (1981) · Psychopharmacology · doi:10.1007/bf00432169 · Cited by 107
Imipramine treatment of alcoholism with comorbid depression
Nunes, E. V., McGrath, P. J., Quitkin, F. M., Stewart, J. P., Harrison, W., TRICAMO, E., & Ocepek‐Welikson, K. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.6.963 · Cited by 107
Wang, R. Y., & Aghajanian, G. K. (1980) · PubMed · Cited by 107
Dreshfield, L. J., Wong, D. T., Perry, K. W., & Engleman, E. A. (1996) · Neurochemical Research · doi:10.1007/bf02527753 · Cited by 106
Wahlestedt, C., Blendy, J. A., Kellar, K. J., Heilig, M. A., V., E., & Ekman, R. (1990) · Brain Research · doi:10.1016/0006-8993(90)90523-e · Cited by 106
Chen, N., & Reith, M. E. A. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63051701.x · Cited by 104
Covey, L. S., Hughes, D. C., Glassman, A. H., Blazer, D. G., & George, L. K. (1994) · Tobacco Control · doi:10.1136/tc.3.3.222 · Cited by 104
The gabaergic hypothesis of depression
Lloyd, K. G., Živković, B., Scatton, B., Morselli, P. L., & Bartholimi, G. (1989) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(89)90123-1 · Cited by 103
5-HT1A Receptor Sensitivity in Major Depression
Cowen, P. J., Power, A. C., Ware, C., & Anderson, I. M. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.3.372 · Cited by 103
Overview: A comparison of withdrawal symptoms from different drug classes
West, R., & Gossop, M. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb03747.x · Cited by 103
Lesch, K., Mayer, S., Disselkamp-Tietze, J., Hoh, A., SCHOELLNHAMMER, G., & Schulte, H. M. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90359-y · Cited by 102
Serotonin and its place in the pathogenesis of depression.
Coppen, A. J., & Doogan, D. P. (1988) · PubMed · Cited by 102
Stahl, S. M. (1994) · PubMed · Cited by 101
Fluoxetine: a review of receptor and functional effects and their clinical implications
Beasley, C. M., Masica, D. N., & Potvin, J. H. (1992) · Psychopharmacology · doi:10.1007/bf02244958 · Cited by 100
Griffiths, R. R., Bigelow, G. E., & Liebson, I. A. (1979) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31748-9 · Cited by 100
Post, R. M., Gold, P. W., Rubinow, D. R., Ballenger, J. C., Bunney, W. E., & Goodwin, F. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90394-0 · Cited by 99
Effects of monoamine reuptake inhibitors on cocaine self-administration in rats
Tella, S. R. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)00438-o · Cited by 99
Regionally selective increases in β-adrenergic receptor density in the brains of suicide victims
Biegon, A. R., & Israeli, M. (1988) · Brain Research · doi:10.1016/0006-8993(88)91453-9 · Cited by 99
Serotonergic mechanisms of cocaine effects in humans
Aronson, S., Black, J. E., McDougle, C. J., Scanley, B. E., Heninger, G. R., Price, L. H., Jatlow, P. L., & Kosten, T. R. (1995) · Psychopharmacology · doi:10.1007/bf02246159 · Cited by 98
Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants
Martin-Iverson, M. T., Leclere, J.-F., & Fibiger, H. C. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90408-9 · Cited by 97
Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system
Sanders‐Bush, E., Breeding, M., Knoth, K. M., & Tsutsumi, M. (1989) · Psychopharmacology · doi:10.1007/bf00634454 · Cited by 97
Chronic cocaine alters limbic extracellular dopamine. Neurochemical basis for addiction
Impérato, A., Mele, A., Scrocco, M. G., & Puglisi‐Allegra, S. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90349-9 · Cited by 97
Mode of action of antidepressant drugs.
Cole, J. O., Branconnier, R. J., Salomon, M. I., & Dessain, E. C. (1983) · PubMed · Cited by 96
Imipramine treatment of cocaine abuse: possible boundaries of efficacy
Nunes, E. V., McGrath, P. J., Quitkin, F. M., Ocepek‐Welikson, K., Stewart, J. W., Koenig, T., Wager, S., & Klein, D. F. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01161-6 · Cited by 95
Depression as a prognostic factor for pharmacological treatment of cocaine dependence.
Ziedonis, D. M., & Kosten, T. R. (1991) · PubMed · Cited by 94
Amino acid levels in depression: A preliminary investigation
Honig, A., Bartlett, J. R., Bouras, N., & Bridges, P. K. (1988) · Journal of Psychiatric Research · doi:10.1016/0022-3956(88)90001-5 · Cited by 94
Desmethylimipramine attenuates cocaine withdrawal in rats
Markou, A., Hauger, R. L., & Koob, G. F. (1992) · Psychopharmacology · doi:10.1007/bf02245878 · Cited by 94
Self-citationCheetham, S. C., Crompton, M. R., Katona, C., Parker, S. J., & Horton, R. W. (1988) · Brain Research · doi:10.1016/0006-8993(88)91211-5 · Cited by 94
Increased REM sleep in rats selectively bred for cholinergic hyperactivity
Shiromani, P. J. (1988) · Neuropsychopharmacology · doi:10.1016/0893-133x(88)90004-8 · Cited by 92
Skolnick, P., Stalvey, L. P., Daly, J. W., Hoyler, E., & Davis, J. N. (1978) · European Journal of Pharmacology · doi:10.1016/0014-2999(78)90391-6 · Cited by 92
Åsberg, M., Ringberger, V., Sjöqvist, F., Thorén, P., Träskman, L., & Tuck, J. R. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977212201 · Cited by 92
Scatton, B., Živković, B., Dedek, J., et al. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33001-6 · Cited by 89
Opponent process and drug dependence: Neurobiological mechanisms
Koob, G. F., Markou, A., Weiss, F., & Schulteis, G. (1993) · Seminars in Neuroscience · doi:10.1016/s1044-5765(05)80043-0 · Cited by 89
Self-citationAnxiogenic behavior in rats during acute and protracted ethanol withdrawal: Reversal by buspirone
Lal, H., Prather, P. L., & Rezazadeh, S. M. (1991) · Alcohol · doi:10.1016/s0741-8329(91)90153-n · Cited by 89
Increased vulnerability to cholinergic stimulation in affective-disorder patients [proceedings].
Ds, J., Risch, C., Parker, D., Huey, L. Y., & Judd, L. L. (1980) · PubMed · Cited by 89
Brain β-adrenoceptor binding sites in antidepressant-free depressed suicide victims
Paermentier, F. D., Cheetham, S. C., Crompton, M. R., et al. (1990) · Brain Research · doi:10.1016/0006-8993(90)91321-7 · Cited by 88
Imipramine as Treatment for Depression in Addicts
Kleber, H. D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.04390010059007 · Cited by 88
Cerebrospinal fluid somatostatin and psychiatric illness
Rubinow, D. R. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90163-0 · Cited by 88
Possible effects of smoke-free inpatient units on psychiatric diagnosis and treatment.
Hughes, J. R. (1993) · PubMed · Cited by 88
Woolverton, W. L. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90618-6 · Cited by 87
Comorbidity and mixed anxiety-depressive disorders: is there epidemiologic evidence?
Wïttchen, H., & Essau, C. A. (1993) · PubMed · Cited by 86
Low levels of somatostatin in human CSF mark depressive episodes
Ågren, H., & Lundqvist, G. (1984) · Psychoneuroendocrinology · doi:10.1016/0306-4530(84)90003-9 · Cited by 86
Szolcsány, J., & Barthó, L. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90183-5 · Cited by 86
Serotonin Reuptake Blockers in Vitro and in Vivo
Fuller, R. W., & WONG, D. T. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198712001-00004 · Cited by 85
Mikkelsen, J. D., Woldbye, D. P. D., Kragh, J., Larsen, P. J., & Bolwig, T. G. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90241-0 · Cited by 85
Wong, D. T., Reid, L. R., Bymaster, F. P., & Threlkeld, P. G. (1985) · Journal of Neural Transmission · doi:10.1007/bf01256471 · Cited by 84
Catecholamine Metabolism and Disposition in Healthy and Depressed Subjects
Maas, J. W. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800160041007 · Cited by 84
A Strong Influence of Serotonin Axons on β-Adrenergic Receptors in Rat Brain
Stockmeier, C. A., Martino, A. M., & Kellar, K. J. (1985) · Science · doi:10.1126/science.2996132 · Cited by 83
Suzdak, P. D., & Gianutsos, G. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90077-2 · Cited by 82
McGregor, A., Lacosta, S., & Roberts, D. C. S. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90181-r · Cited by 82
Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.
Sanders‐Bush, E., & Breeding, M. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)19989-8 · Cited by 81
MHPG Excretion in Depressive Disorders: Relation to Clinical Subtypes and Desynchronized Sleep
Schildkraut, J. J., Keeler, B. A., Papousek, M., et al. (1973) · Science · doi:10.1126/science.181.4101.762 · Cited by 81
Withdrawal symptoms and alcohol dependence: fruitful mysteries★
Edwards, G. (1990) · British Journal of Addiction · doi:10.1111/j.1360-0443.1990.tb01665.x · Cited by 79
Kleven, M. S., & Woolverton, W. L. (1993) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(93)90067-z · Cited by 79
Overstreet, D. H., Russell, R. W., Crocker, A. D., & Schiller, G. D. (1984) · Brain Research · doi:10.1016/0006-8993(84)91044-8 · Cited by 78
Bosker, F. J., van Esseveldt, K. E., Klompmakers, A. A., & Westenberg, H. G. M. (1995) · Psychopharmacology · doi:10.1007/bf02246110 · Cited by 77
Riemann, D. W., Hohagen, F., Krieger, S., Gann, H., Müller, W. E., Olbrich, R., Wark, H.-J., Bohus, M., Löw, H., & Berger, T. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90006-x · Cited by 77
Goodnough, D. B., & Baker, G. B. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62062262.x · Cited by 77
Cocaine-induced reduction of brain neuropeptide Y synthesis dependent on medial prefrontal cortex.
Wahlestedt, C., Karoum, F., Jaskiw, G. E., Wyatt, R. J., Larhammar, D., Ekman, R., & Reis, D. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2078 · Cited by 76
Green, A. R., Johnson, P., & Nimgaonkar, V. L. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb11063.x · Cited by 76
Markou, A., & Koob, G. F. (1992) · PubMed · Cited by 76
Self-citationFrazer, A., Hess, M. E., MENDELS, J., et al. (1978) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31330-3 · Cited by 76
Richter, R. M., Pich, E. M., Koob, G. F., & Weiss, F. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11365-4 · Cited by 75
Serotonin dysfunction disorders: a behavioral neurochemistry perspective.
Petty, F., Davis, L. L., Kabel, D., & Kramer, G. L. (1996) · PubMed · Cited by 73
Hjorth, S., & Auerbach, S. B. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90062-0 · Cited by 73
Animal models of psychiatric disorders
Gordon, J. A., & Dzirasa, K. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.004 · Cited by 73
Role for the Mesocortical Dopamine System in the Motivating Effects of Cocaine
Koob, G. F., Caine, S. B., Markou, A., Pulvirenti, L., & Weiss, F. (1994) · PsycEXTRA Dataset · doi:10.1037/e495842006-002 · Cited by 71
Self-citationAndrews, N., & File, S. E. (1993) · Psychopharmacology · doi:10.1007/bf02247359 · Cited by 71
Gepirone in the Treatment of Major Depression
JENKINS, S. W., Robinson, D. S., Lf, F., ANDARY, J. J., MESSINA, M. E., & REICH, L. A. (1990) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199006001-00014 · Cited by 71
Rosenberg, P. A., & Li, Y. (1995) · Brain Research · doi:10.1016/0006-8993(95)00668-g · Cited by 70
Differential Effect of Gepirone on Presynaptic and Postsynaptic Serotonin Receptors
Blier, P. U., & de Montigny, C. (1990) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199006001-00004 · Cited by 70
Mood, major depression, and fluoxetine response in cigarette smokers
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.398 · Cited by 70
Chronic cocaine administration alters corticotropin-releasing factor receptors in the rat brain
Goeders, N. E., Bienvenu, O. J., & Souza, E. B. D. (1990) · Brain Research · doi:10.1016/0006-8993(90)90794-c · Cited by 68
Winokur, G., & Pitts, F. N. (1965) · Journal of Psychiatric Research · doi:10.1016/0022-3956(65)90021-x · Cited by 68
Cerebrospinal fluid neuropeptide Y in depression and schizophrenia
Berrettini, W. H. (1987) · Neuropsychopharmacology · doi:10.1016/0893-133x(87)90013-3 · Cited by 68
Gillin, J. C., Pulvirenti, L., Withers, N. W., Golshan, S., & Koob, G. F. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90019-1 · Cited by 67
Increased sensitivity to dopaminergic agonists after repeated electroconvulsive shock (ECS) in rats
Wielosz, M. (1981) · Neuropharmacology · doi:10.1016/0028-3908(81)90024-1 · Cited by 66
Chen, N., & Reith, M. E. A. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24047-2 · Cited by 66
Maj, J., Wędzony, K., & Klimek, V. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90803-x · Cited by 63
Depression in the patient with Parkinson's disease.
Mayeux, R. P. (1990) · PubMed · Cited by 63
Mason, B. J. (1996) · JAMA · doi:10.1001/jama.275.10.761 · Cited by 62
Hjorth, S., Bengtsson, H. J., & Milano, S. P. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00779-0 · Cited by 61
Auerbach, S. B., & Hjorth, S. (1995) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00171317 · Cited by 61
Heal, D. J., Lister, S., Smith, S. L., et al. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90214-9 · Cited by 61
Montis, M. G. D., Devoto, P., Gessa, G. L., Meloni, D., Porcella, A., Saba, P., Serra, G., & Tagliamonte, A. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90589-x · Cited by 60
France, R. D., Urban, B. J., Krishnan, K. R. R., Bissett, G., Bánki, C. M., Nemeroff, C. B., & Speilman, F. J. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90108-4 · Cited by 60
Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible
Malin, D. H. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00202-2 · Cited by 60
Alprazolam and benzodiazepine dependence.
Sellers, E. M., Ciraulo, D. A., DuPont, R. L., Griffiths, R. R., Kosten, T. R., Romach, M. K., & WOODY, G. E. (1993) · PubMed · Cited by 60
Repeated ECS differentially affects rat brain 5-HT1A and 5-HT2A receptor expression
Burnet, P. W. J., Mead, A., Eastwood, S. L., Lacey, K., Harrison, P. J., & Sharp, T. (1995) · Neuroreport · doi:10.1097/00001756-199504190-00019 · Cited by 58
Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment.
Riva, M. A., & Creese, I. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09099-6 · Cited by 57
Florin, S. M., Kuczenski, R. T., & Segal, D. S. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10561-2 · Cited by 57
Mishira, R., Janowsky, A. J., & Sulser, F. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90246-2 · Cited by 56
Reduction in cortical 5HT2 receptor sensitivity after continuous gepirone treatment
Eison, A. S., & Yocca, F. D. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90648-x · Cited by 56
Childhood Psychopathology in Families with Multigenerational Alcoholism
Hill, S. Y., & Muka, D. H. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199211000-00004 · Cited by 56
Heal, D. J., & Green, A. R. (1978) · Neuropharmacology · doi:10.1016/0028-3908(78)90046-1 · Cited by 55
Tricyclic Antidepressants in the Treatment of Depression Associated with Alcoholism
Ciraulo, D. A., & Jaffe, J. H. (1981) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198105000-00006 · Cited by 55
Riva, M. A., & Creese, I. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09098-4 · Cited by 55
Yu, O., Chiu, T. H., & Rosenberg, H. C. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20987-9 · Cited by 54
Cross, J. A., & Horton, R. W. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90425-0 · Cited by 54
Scopolamine-induced muscarinic supersensitivity in normal man: Changes in sleep
Sitaram, N., Moore, A. M., & Gillin, J. C. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90022-2 · Cited by 53
Gepirone Treatment of Atypical Depression
McGrath, P. J., Stewart, J. W., Quitkin, F. M., Wager, S. G., JENKINS, S. W., Archibald, D., Stringfellow, J., & Robinson, D. S. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199410000-00011 · Cited by 52
Stahl, S. M. (1993) · PubMed · Cited by 51
Further evidence for GABA-ergic mechanisms in the action of benzodiazepines.
Vv, Z., Ostrovskaya, R. U., Kozhechkin, S. N., et al. (1977) · PubMed · Cited by 51
Pharmacological effects of paroxetine after repeated administration to animals
Nelson, D. R., Thomas, D. R., & Johnson, A. M. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07162.x · Cited by 50
Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls.
Gjerris, A., Widerlöv, E., Werdelin, L., & Ekman, R. (1992) · PubMed Central · Cited by 49
Repeated Administration of Antidepressants Enhances Agonist Affinity for Mesolimbic D2-Receptors
Klimek, V., & Maj, J. (1989) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1989.tb06525.x · Cited by 49
Bel, N., & Artigas, F. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20754-6 · Cited by 49
Samson, H. H., Haraguchi, M., Tolliver, G. A., & Sadeghi, K. G. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90395-x · Cited by 48
Effects of single and chronic treatment with tranylcypromine on extracellular serotonin in rat brain
Ferrer, A., & Artigas, F. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90717-x · Cited by 48
Relapse of depression after rapid depletion of tryptophan
Leyton, M., Young, S. N., & Benkelfat, C. (1997) · The Lancet · doi:10.1016/s0140-6736(05)61726-6 · Cited by 48
Maj, J., Papp, M., Skuza, G., et al. (1989) · Journal of Neural Transmission · doi:10.1007/bf01244989 · Cited by 47
Paul, I. A., Duncan, G. E., Powell, K. R., et al. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22191-7 · Cited by 46
Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study.
Titievsky, J., Seco, G., Barranco, M., et al. (1982) · PubMed · Cited by 45
Preliminary report: double-blind, placebo-controlled study of fluoxetine in depressed alcoholics.
Cornelius, J. R., Salloum, I. M., Cornelius, M. D., Perel, J. M., Ehler, J. G., Jarrett, P. J., Levin, R. L., Black, A., & Mann, J. J. (1995) · PubMed · Cited by 44
Stability of plasma GABA at four-year follow-up in patients with primary unipolar depression
Petty, F., Kramer, G. L., Fulton, M., Davis, L. L., & Rush, A. J. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00226-s · Cited by 43
Gg, N., Zis, A. P., Damsma, G., et al. (1991) · PubMed · Cited by 43
Effect of Nicotine Replacement on the Cigarette Withdrawal Syndrome
West, R. J., Jarvis, M. J., Russell, M. A., et al. (1984) · British Journal of Addiction · doi:10.1111/j.1360-0443.1984.tb03858.x · Cited by 43
Pälvimäki, E.-P., Laakso, A., Kuoppamäki, M., Syvälahti, E. K. G., & Hietala, J. A. (1994) · Psychopharmacology · doi:10.1007/bf02245579 · Cited by 42
Manier, D. H., Gillespie, D. D., Steranka, L. R., et al. (1984) · Cellular and Molecular Life Sciences · doi:10.1007/bf01946651 · Cited by 42
Mj, S., & Thornberry, J. F. (1977) · PubMed · Cited by 41
Sleep Studies in Affective Illness: Diagnostic, Therapeutic, and Pathophysiological Implications
Gillin, J. C. (1983) · Psychiatric Annals · doi:10.3928/0048-5713-19830501-02 · Cited by 40
Nalepa, I., & Vetulani, J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03487.x · Cited by 40
Benzodiazepine self-administration in animals and humans: a comprehensive literature review.
Griffiths, R. R., & Na, A. (1980) · PubMed · Cited by 39
THE USE OF ANTIDEPRESSANTS WITH METHADONE IN DEPRESSED MAINTENANCE PATIENTS *
WOODY, G. E., O’Brien, C. P., McLellan, A. T., Marcovici, M., & Evans, B. D. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb39485.x · Cited by 39
Cerebrospinal Fluid and Urinary Biogenic Amines in Depressed Patients and Healthy Controls
Davis, J. M. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800320015002 · Cited by 39
Koe, B. K., Koch, S. W., Lebel, L. A., et al. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90262-7 · Cited by 39
A 30‐year follow‐up study of the sons of alcoholic men
Knop, J., Goodwin, D. W., Jensen, P., Penick, E. C., Pollock, V. E., Gabrielli, W. F., Teasdale, T. W., & Mednick, S. A. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb05360.x · Cited by 38
Bonanno, G., & Raiteri, M. (1987) · Synapse · doi:10.1002/syn.890010306 · Cited by 37
Heilig, M. A. (1995) · Neurochemistry International · doi:10.1016/0197-0186(94)00150-s · Cited by 37
A Possible Role of Serotonin Receptors in Antidepressant Drug Action
Snyder, S. H., & Peroutka, S. J. (1982) · Pharmacopsychiatry · doi:10.1055/s-2007-1019525 · Cited by 36
5HT2 binding sites after mianserin: comparison of loss of sites and brain levels of drug
Sanders‐Bush, E., Breeding, M., & Roznoski, M. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90151-8 · Cited by 36
Engleman, E. A., Robertson, D. W., Thompson, D. C., et al. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66020599.x · Cited by 36
Ro15‐4513 Attenuates the Consumption of Ethanol in Deprived Rats
June, H. L., Lummis, G. H., Colker, R. E., et al. (1991) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1991.tb00538.x · Cited by 36
Esposito, E., Kruszewska, A., Ossowska, G., & SAMANIN, R. (1987) · Psychopharmacology · doi:10.1007/bf00187263 · Cited by 35
Green, A. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90057-8 · Cited by 35
Antidepressants given repeatedly increase the behavioural effect of dopamine D-2 agonist
Maj, J., Rogóż, Z., Skuza, G., & Sowińska, H. (1989) · Journal of Neural Transmission · doi:10.1007/bf01247108 · Cited by 35
The serotonin/noradrenaline-link in brain
Manier, D. H., Gillespie, D. D., Sanders‐Bush, E., et al. (1987) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00177710 · Cited by 35
Treatment of Intravenous Drug Users with AIDS: The Role of Methadone Maintenance
Batki, S. L. (1988) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1988.10524497 · Cited by 34
Mixed anxiety and depression: diagnostic issues.
Boulenger, J.-P., & Lavallée, Y. J. (1993) · PubMed · Cited by 33
BALAKLEEVSKY, A., Colombo, G., Fadda, F., et al. (1990) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045036 · Cited by 33
Barkai, A. I., Durkin, M. M., & Nelson, H. D. (1990) · Brain Research · doi:10.1016/0006-8993(90)90829-z · Cited by 32
Nicotine abstinence syndrome precipitated by an analog of neuropeptide FF
Malin, D. H. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02279-1 · Cited by 32
Aubin, H., Tilikete, S., & Barrucand, D. (1996) · PubMed · Cited by 32
June, H. L., Hughes, R. W., Spurlock, H. L., & Lewis, M. J. (1994) · Psychopharmacology · doi:10.1007/bf02245074 · Cited by 31
Paul, S. M., & Crews, F. T. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90104-1 · Cited by 31
McKinney, W. T. (1988) · Springer eBooks · doi:10.1007/978-1-4684-5430-7 · Cited by 31
Florin, S., Kuczenski, R. T., & Segal, D. (1994) · Neuropsychopharmacology · doi:10.1038/sj.npp.1380146 · Cited by 31
Cited by
Sorted by citations
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Reconsidering anhedonia in depression: Lessons from translational neuroscience
Treadway, M. T., & Zald, D. H. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.006 · Cited by 1,579
Ikemoto, S. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.05.004 · Cited by 1,477
Addiction and the brain antireward system
Koob, G. F., & Le Moal, M. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.103006.093548 · Cited by 1,457
The association of cigarette smoking with depression and anxiety: a systematic review
Fluharty, M., Taylor, A. E., Grabski, M., & Munafò, M. R. (2017) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw140 · Cited by 1,299
Metadata
- Authors
- Markou, A.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Markou, A
- Venue
- Neuropsychopharmacology
- Published
- 1998-03
- Volume
- 18
- Issue
- 3
- Pages
- 135-174
- ISSN
- 0893-133X (ISSN-L)
- OpenAlex
- W2042152382
- Cited by
- 767
- References
- 456
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 24 · 2023: 21 · 2022: 17 · 2021: 30 · 2020: 22 · 2019: 15 · 2018: 26 · 2017: 21 · 2016: 26 · 2015: 37 · 2014: 28 · 2013: 28 · 2012: 26
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p50da004060-13)
- National Institute on Drug Abuse (DA 00213, DA04060, DA 00112)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- depression, drug addiction, self-medication hypothesis, comorbidities, reward and motivation, neurotransmitter systems, limbic system, stimulant use disorder, opioid use disorder, ethanol dependence, nicotine dependence, benzodiazepine dependence, drug-induced depression, serotonin, norepinephrine, dopamine, GABA, neuropeptide Y, somatostatin, corticotropin-releasing factor
- MeSH terms
- Animals, Brain, Corticotropin-Releasing Hormone, Depressive Disorder, Neuropeptide Y, Norepinephrine, Serotonin, Comorbidity, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review